Clinical Characteristics of Toxicities of Immune Checkpoint Inhibitors and Their Impact on Efficacy in Solid Cancers: An Analysis of Real-World Data in Moroccan Patients
Our results indicated that ICIs have the potential to induce irAEs in patients with solid tumors. These adverse effects were commonly GI. The development of irAEs was associated with improved effectiveness of ICI treatment across different malignancies.
Authors
- Hassan Errihani (ORCID: https://orcid.org/0000-0002-3389-0017)
- Saber Boutayeb (ORCID: https://orcid.org/0000-0003-1642-9330)
- Mohamed Khalis (ORCID: https://orcid.org/0000-0003-4639-049X)
- Hanane Inrhaoun
- Hind Mrabti (ORCID: https://orcid.org/0000-0002-6728-6707)
- I. El Ghissassi
- Loubna Omri
- Sarah Naciri
- Sihame Lkhoyaali (ORCID: https://orcid.org/0000-0003-3119-7654)
- Badiaa Batlamous
- Magaly-Gwen-Farnely Nguema-Mipaka
Institutions
- Mohammed V University (MA)
- Instituts Supérieurs des Professions Infirmières et Techniques de Santé (MA)
- Université Mohammed VI des Sciences et de la Santé (MA)
- Institut National d'Oncologie (MA)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1200/go-24-00312
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05